Investigations on the behaviour of superparamagnetic nanoparticles under the influence of a high gradient magnetic field in the vascular system is required for a better under-standing of magnetic drug targeting. The influence on the particle transport of the non-Newtonian and Newtonian properties of blood as well as the influence of the heart rate was therefore studied. A analytical model was developed and the calculation of particle trajectories is presented and evaluated. The results show that the non-Newtonian properties of the blood have a positive influence on the number of retended nanoparticles. The calculations also showed that the number of retained nanoparticles was lower in oscillatory flow profile than in steady flow. The influence of the heart rate can be neglected for Womersley numbers smaller than 1.5.
INTRODUCTION
Magnetic particles loaded with a drug can be directed to a desired body compartment with an external magnetic field after intravascular application (Magnetic Drug Targeting, MDT). This promising new method can be used for cancer treatment to archieve high concentration of the respective substance in the tumor region. The drug-particle compos-ite can be applied to the patient by several procedures, e.g. intra-arterial [1] or intra-luminal, and subsequently moved to the region of interest by an external magnetic field [1] . Examples for the application of this method are local tumor therapy by using a cytostatic drug or a signal inhibitor coupled to a magnetic carrier [1] , aerosol therapy for diseases of the lung [2] , and gene therapy by magnetofection [3 -5] . The main advantages of these therapies are the accumulation of the drug at the targeted area to achieve a therapeutical relevant concentration, and the decrease of undesirable systemic side effects. For an intravascular application of the nanoparticles, information about local flow behavior is necessary. Delivery of drugs in general and of chemotherapeutic agents in particular to a specific region of the body with a minimum of systemic side effects is the major challenge to nearly all treatments. In chemotherapy, for example, systemic application of high doses is required for a sufficient concentration at the tumor site. Therefore, classic chemotherapy is limited by the systemic side effects. In the past, several carrier systems for the specific transport of therapeutic agents have been devel-oped [1, 6 -12] .
MDT is basically the accumulation of a drug in a certain part of the body with the help of magnetic nanoparticles and appropriate magnetic fields. The drug molecules are chemi-cally coupled to an active component (e.g. magnetite) and thus transferred to a pharma-ceutical stable micro-carrier system [1] . This complex can be applied by several means into the blood circulation (e.g. intra-vascular, intra-arterial or intraluminal) and can be subsequently controlled by an external magnetic field. For in-vivo application nanoparti-cles must be biocompatible; this can be achieved by coating the magnetic spheres with e.g. starch. This coating is also necessary to minimize agglutination due to van-der Waals forces. As far as toxicity is concerned recent studies showed that there are nearly no side effects caused by the iron nanoparticles themselves [11, 13 -15] . Almost all properties of the nanoparticles (e.g. size and material, coating, zeta potential) influence their in-vivo application and biodistribution. Altogether, magnetic drug targeting offers an improved alternative (in comparison to present methods) for prolonged chemotherapy duration and a higher concentration of drugs. To be able to predict the particle behaviour a physical model to simulate different flux conditions was developed [16] .
The method presented here enables the optimization of the necessary magnetic fields by describing the particle's trajectory as a function of the magnetic flux density gradient, the position of the magnet with respect to the vessel, the heart rate and the viscosity of the blood.
COMPUTATIONAL METHODS

GEOMETRY AND FLOW MODELLING
The geometry of the analyzed flow represents the magnetic nanoparticles and the blood flow through a magnetic field ( Figure 1 ). Due to their superparamagnetic properties, the nanoparticles will be deflected by the magnetic field gradient towards the vessel wall. Once they reach the vessel wall, they adhere there. The calculation of the trajectories supports the design and construction of apropriate field sources as well as their positioning during tumor treatment. The magnetic force on a superparamagnetic particle within an external magnetic field is defined as (1) where m denotes the magnetic moment of the particle and B the absolute value of the external flux densitiy. Eq. 1 is valid if the vector of the magnetic moment is parallel to the external magnetic field. For magnetic flux densities above 100 -
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GOVERNING EQUATIONS AND METHODS
For further calculations we assume a laminar flow with the flow velocity uF. Thus the Stokes drag force on a nanoparticle (diameter 2a, density r) moving with the velocity up in x-direction is given by (2) where as h is the viscosity of the fluid. The influence of diffusion and Brownian motion will be neglected for all further calculations. The influence of Brownian motion and the dynamics of magnetization are studied in [17, 18] . The equations of motion for all three dirctions of space (x, y, z) can be defined as
X,Y and Z denotes the time-dependent position of the particle. For further simplifications Eqs. 3 -5 can be written in a non-dimensional manner using the following transformations: (6) By combining Eqs. 3 -5 with Eq. 6 the non-dimensional equations of motion are given by (7) (8) (9) with the dimensionless abbreviations (10)
Here Eq. 10 describes the inertia term of the system, Eq. 11 is a force factor which is defined by the ratio of magnetic force to Stokes drag force, and eq. 12 defines the geometry factor which describes the ratio of the diameter of the vessel to the diameter of the coil.
SIMPLIFIED 2-DIMENSIONAL MODEL
MAGNETIC FIELD
For simplification the full 3-dimensional description will be reduced to the x-z-plane for all further calculations. The external magnetic field is modelled by using a dipole approach. The dipole is a common far-field model for magnetic fields. Thus, the mag-netic flux density as a function of the remanent flux density B r and the angle q is given by (13) with r 2 = (Wx -W) 2 + (Wdu -dW) 2 and cosq = Wdu/r. Equation 13 leads to a magnetic flux densitiy gradient (14)
LAMINAR, NEWTONIAN FLOW
The laminar flow profile of a Newtonian fluid in a cylindrical tube can be written in non-dimensional coordinates as (15) 
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LAMINAR, NON-NEWTONIAN FLOW
Real blood is a non-Newtonian fluid, which can be modeled with a power law [19] . The shear rate in a power law fluid is given by (16) with the boundary at the vessel wall (17) While g · is the shear rate, K is the flow consistency index, n is the power law index and dp/L is the pressure gradient along the vessel. From Eqs. 16 and 17 the calculation of the laminar flow profile of a non-Newtonian fluid can be calculated as
OSCILLATING FLOW IN RIGID VESSELS
For simplification only rigid vessels are taken into account. The influence of the pulsatile flow behaviour is determined by the Womersley number a [20, 21] . The Womersley number depends on the vessel's diameter D, the angular frequency w, the densitiy r F and the viscosity h of the fluid.
Therefore, the oscillatory part of the flow profile can be written as (20) where J o denotes the first kind complex Bessel function and i denotes the imaginary unit. The complete flow velocity is the sum of the osciallatory part (Eq. 20) and the stationary part (Eq. 15).
ADHESION AND DETACHMENT OF PARTICLES AT THE VESSEL WALL
While the detachment of particles is of great importance for many technologies such as, filtration technology [22] , it must be avoided when transporting drugs to a tumours region. A detachment of the drugs from the vessel wall will impede the uptake of the drugs into the tumor tissue -the therapeutic advantage would be lost.
If the detachment forces are larger than the adhesive forces, detachment is possible by lift-off, rolling or sliding. Detaching forces are, for example, Stokes drag force or electrostatic forces, where adhesive forces are mainly the magnetic force, or van der Waals forces between the particle and the vessel wall. The order of magnitude of the detachment forces was empirically estimated for Reynolds numbers up to 30 [23, 24] . The detachment force with flow in the x-direction is given by (21) With k 1 = 2.268. With the help of Eqs. 1 and 6 the condition for the balance of forces in non-dimensional coordinates are defined by:
This gives an equilibrium force G, which is defined by (23) This equilibrium is stable if the following condition is fulfilled.
The parameters which were used to carry out the simulations are given in Table 1 . 
RESULTS
INFLUENCE OF THE DISTANCE BETWEEN VESSEL AND MAGNETIC COIL TIP
The computational results for different distances between magnetic field source and blood vessel, d, assuming different fluid behaviors are shown in Figures 2 -4 .
INFLUENCE OF MAGNETIC FIELD STRENGTH, FLOW VELOCITY, DIAMETER OF THE VESSEL AND GEOMETRY OF THE COIL TIP
The influence of the two parameters b (which is responsible for the magnetic field strength and the mean flow velocity) and d (which is responsible for the geometry of the vessel and the coil tip) are shown in Figure 5a and b. An increase in bleads to an increase in the number of adhered particles at the vessel wall. The parameter b depends mainly on the magnetic moment m, which is proportional to a 3 and the flow velocity. For a constant magnetic moment, b decreases when the flow velocity increases. The influence of d is very small and can be neglected.
DATA EVALUATION
The relation between the fraction of retained nanoparticles and the distance between mag-netic field source and vessel wall is plotted in Figure 6 . As expected, the fraction of retained nanoparticles decreases with increasing distance. The difference between steady and pulsatile flow profile can be neglected if the Womer-sley number is smaller than about 1.4. At a Womersley number of a = 21.7, which is a common value for the proximate aorta [26] , only 32 % of nanoparticles are retained at d = 0.1, whereas for a = 1.38, 48 % of nanoparticles are captured. At a = 6.15, which is a common value for the left coronary artery [26] only 40 % of all nanoparticles can be captured. The influence of the heartbeat decreases with increasing proximity to the heart and is almost zero in tumor tissue [26] . The larger amount of retained nanoparticles in a non-Newtonian fluid in compared to a Newtonian fluid can be explained by the smaller velocities due to larger shear rates.
DISCUSSION
The simplified calculation of the particle trajectories presented in this paper provides a mathematical proof-of-principle of the magnetic drugtargeting therapy. With the help of fully analytical equations, all necessary influencing parameters, such as non-Newtonian and pul-
52023-5 Applied Rheology
Volume 18 · Issue 5 satile flow profiles can be investigated. Experiments with animals have shown that magnetic drug-targeting is feasible [1, 27, 28] . Furthermore, the construction of targeting magnets is easy with the help of the calculated particle trajectories. Since the calculations are very fast to carry out, the optimal location of the magnet can be deter-mined. However, for physical reasons it is not possible to generate local flux density maxima and thus local force maxima far away of the poleshoe. Therefore MDT is only feasible for the treatment of near surface tumors like breast cancer or tumors in the head area. 
